Congenital Pseudarthrosis of Tibia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-01
Clinical Trial Update: A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia. [Phase 3]
Novadip Biosciences is conducting a Phase 3 study to assess the effectiveness and safety of NVD003 for congenital pseudarthrosis of the tibi…